Empowered Funds’s Veracyte VCYT Stock Holding History

Empowered Funds’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-69,167	Closed	-$2.23M	–	2296
2026 Q1	$2.23M	Buy	+69,167	New	+$2.56M	0.01%	1052
2023 Q2	–	Sell	-32,494	Closed	-$725K	–	1182
2023 Q1	$725K	Buy	+32,494	New	+$785K	0.04%	351

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Empowered Funds's VCYT Position: Q2 2026 in Review

Empowered Funds sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 69,167 shares — an estimated $2.23M sold.

Empowered Funds first reported a position in VCYT in Q1 2023 and held it in 2 quarters. The position peaked at $2.23M in Q1 2026. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Empowered Funds reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Empowered Funds sold 69,167 Veracyte shares in Q2 2026, an estimated $2.23M.
Empowered Funds first reported a position in Veracyte in Q1 2023 and held it in 2 quarters.
Empowered Funds's Veracyte position peaked at $2.23M in Q1 2026.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.